
|Articles|March 12, 2014
Almac Expands Asia Pacific Operations
Author(s)BioPharm International Editors
Almac expands technical, project, and operational resources in Asia.
Advertisement
Almac
reported the expansion of its clinical services and technologies capabilities to include technical, project, and operational resources in Asia. The company has established regional hubs in Singapore and Japan to improve the need to conduct clinical trials in Asia and manage global trials from the region.
As part of the expansion, Almac is building a new secondary packaging facility in Singapore, which is expected to open by the end of 2014.
Source:
Almac
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
New $82 Million Biopharma Launch Targets Rare Disease Development With AI-Driven Strategy
2
Next-Generation Modalities Drive New Antibody Discovery
3
Green Chemistry’s Role in Advancing US Chemical Innovation
4
Industry Outlook 2026: Biopharma Industry Confronts Skills Shortage with Strategic Automation (Part 2)
5




